Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether high flow nasal oxygen (HFNO) therapy is non inferior to non invasive ventilation (NIV) in the immediate treatment of patients with acute hypercapnic ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Montpellier
Collaborators
NCT05011877 · Acute Hypercapnic Respiratory Failure
NCT03033251 · Exacerbation Copd, Acute Respiratory Distress, and more
NCT06007495 · Acute Hypercapnic Respiratory Failure, Acute Hypoxemic Respiratory Failure
NCT06047405 · Hypercapnic Respiratory Failure
NCT06204276 · Acute Hypoxemic Respiratory Failure, Acute Hypercapnic Respiratory Failure
Montpellier University Hospital
Montpellier
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions